BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16487171)

  • 1. Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel.
    Reddy KS
    Br J Haematol; 2006 Mar; 132(6):705-22. PubMed ID: 16487171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukemia FISH panel: impact on diagnosis.
    Nelson BP; Gupta R; Dewald GW; Paternoster SF; Rosen ST; Peterson LC
    Am J Clin Pathol; 2007 Aug; 128(2):323-32. PubMed ID: 17638669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia.
    Lu G; Kong Y; Yue C
    Cancer Genet Cytogenet; 2010 Jan; 196(1):56-63. PubMed ID: 19963136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of 5'IGH deletions in B-cell chronic lymphocytic leukemia.
    Quintero-Rivera F; Nooraie F; Rao PN
    Cancer Genet Cytogenet; 2009 Apr; 190(1):33-9. PubMed ID: 19264231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined cytogenetic testing and fluorescence in situ hybridization analysis in the study of chronic lymphocytic leukemia and multiple myeloma.
    Wiktor A; Van Dyke DL
    Cancer Genet Cytogenet; 2004 Aug; 153(1):73-6. PubMed ID: 15325099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation.
    Cuneo A; Bigoni R; Negrini M; Bullrich F; Veronese ML; Roberti MG; Bardi A; Rigolin GM; Cavazzini P; Croce CM; Castoldi G
    Cancer Res; 1997 Mar; 57(6):1144-50. PubMed ID: 9067285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection.
    Smonskey MT; Block AW; Deeb G; Chanan-Khan AA; Bernstein ZP; Miller KC; Wallace PK; Starostik P
    Am J Clin Pathol; 2012 Apr; 137(4):641-6. PubMed ID: 22431542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis.
    Cavazzini F; Hernandez JA; Gozzetti A; Russo Rossi A; De Angeli C; Tiseo R; Bardi A; Tammiso E; Crupi R; Lenoci MP; Forconi F; Lauria F; Marasca R; Maffei R; Torelli G; Gonzalez M; Martin-Jimenez P; Maria Hernandez J; Rigolin GM; Cuneo A
    Br J Haematol; 2008 Aug; 142(4):529-37. PubMed ID: 18547320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genomic abnormalities detected by panel fluorescence in situ hybridization in chronic lymphocytic leukaemia].
    Li Q; Xue YQ; Jiang HY; Pan JL; Wu YF; Yang YB
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):324-6. PubMed ID: 15952127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
    Wu Y; Xue Y; Chen S; Yao L; Jiang H; Zhang J; Shen J; Pan J; Wang Y; Bai S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinico-pathological impact of cytogenetic subgroups in B-cell chronic lymphocytic leukemia: experience from India.
    Amare PS; Gadage V; Jain H; Nikalje S; Manju S; Mittal N; Gujral S; Nair R
    Indian J Cancer; 2013; 50(3):261-7. PubMed ID: 24061469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
    N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis.
    Athanasiadou A; Stamatopoulos K; Tsompanakou A; Gaitatzi M; Kalogiannidis P; Anagnostopoulos A; Fassas A; Tsezou A
    Cancer Genet Cytogenet; 2006 Jul; 168(2):109-19. PubMed ID: 16843100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The interphase fluorescence in situ hybridization (I-FISH) technique in patients with chronic lymphatic leukemia (CLL)].
    Michalová K; Zemanová Z; Cmunt E; Karban J; Brezinová J; Sindelárová L; Kurková S; Kubcová S; Schwarz J
    Cas Lek Cesk; 2000 Jun; 139(11):334-8. PubMed ID: 10953412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
    Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
    Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin heavy chain (IGH@) translocations negatively impact treatment-free survival for chronic lymphocytic leukemia patients who have an isolated deletion 13q abnormality.
    Gerrie AS; Bruyere H; Chan MJ; Dalal CB; Ramadan KM; Huang SJ; Toze CL; Gillan TL
    Cancer Genet; 2012 Oct; 205(10):523-7. PubMed ID: 22939229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia.
    Ripollés L; Ortega M; Ortuño F; González A; Losada J; Ojanguren J; Soler JA; Bergua J; Coll MD; Caballín MR
    Cancer Genet Cytogenet; 2006 Nov; 171(1):57-64. PubMed ID: 17074592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
    Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
    Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.